# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Dan Leonard maintains CryoPort (NASDAQ:CYRX) with a Neutral and lowers the price target from $17 to $7.
Jefferies analyst Matthew Stanton downgrades CryoPort (NASDAQ:CYRX) from Buy to Hold and lowers the price target from $20 to...
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and lowers the price target from $18 to $11.
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.39) by 2...